Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by VGYAAN Pharmaceuticals LLC, priced at $261.3184 per EA under NDC 72664061128. Its NADAC has been published 94 times since Apr 17, 2024.
FDA first approved this application on Aug 13, 2021. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Leuprolide Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
VGYAAN Pharmaceuticals LLCNDC
72664061128
Classification
Generic
Dosage Form
KIT
Effective Date
1/21/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA213829FDA Approved
8/13/2021
TE Code
AP
On Market Since
10/25/2020
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 94 times since Apr 17, 2024, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $261.3184 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $217.5983 (Jul 17, 2024) |
| 52-week high | $261.3184 |
| 52-week low | $241.4400 |
| Median price | $264.5017 |
| Average price | $265.9443 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 94 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+8.2%
3Y
N/A
5Y
N/A
All
+13.4%
Last surveyed Jan 28, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
VGYAAN Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Leuprolide Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by VGYAAN Pharmaceuticals LLC, is $261.3184 per EA (NDC 72664061128), effective Jan 28, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has risen 13.4%. It has been tracked across 94 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Apr 17, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $217.5983 (Jul 17, 2024) to a high of $301.8717 (Sep 10, 2025), with a median of $264.5017 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEUPROLIDE 2WK 14 MG/2.8 ML KT, is $197.6060 per EA — about 24% below LEUPROLIDE 2WK 14 MG/2.8 ML KT.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 72664061128) is labeled by VGYAAN Pharmaceuticals LLC, and CMS classifies it as a generic product.